Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Inhibitor of CD147 Suppresses T Cell Activation and Recruitment in CVB3-Induced Acute Viral Myocarditis.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE
- Publication Information:
Original Publication: Basel, Switzerland : MDPI
- Subject Terms:
- Abstract:
Viral myocarditis (VMC) is a common disease characterized by cardiac inflammation. AC-73, an inhibitor of CD147, disrupts the dimerization of CD147, which participates in the regulation of inflammation. To explore whether AC-73 could alleviate cardiac inflammation induced by CVB3, mice were injected intraperitoneally with AC-73 on the fourth day post-infection (dpi) and sacrificed on the seventh dpi. Pathological changes in the myocardium, T cell activation or differentiation, and expression of cytokines were analyzed using H&E staining, flow cytometry, fluorescence staining and multiplex immunoassay. The results showed that AC-73 alleviated cardiac pathological injury and downregulated the percentage of CD45 + CD3 + T cells in the CVB3-infected mice. The administration of AC-73 reduced the percentage of activated CD4 + and CD8 + T cells (CD69 + and/or CD38 + ) in the spleen, while the percentage of CD4 + T cell subsets in the spleen was not changed in the CVB3-infected mice. In addition, the infiltration of activated T cells (CD69 + ) and macrophages (F4/80 + ) in the myocardium also decreased after the AC-73 treatment. The results also showed that AC-73 inhibited the release of many cytokines and chemokines in the plasma of the CVB3-infected mice. In conclusion, AC-73 mitigated CVB3-induced myocarditis by inhibiting the activation of T cells and the recruitment of immune cells to the heart. Thus, CD147 may be a therapeutic target for virus-induced cardiac inflammation.
- References:
Int J Mol Sci. 2021 Dec 24;23(1):. (PMID: 35008603)
Cell Biosci. 2022 Nov 16;12(1):184. (PMID: 36384812)
Biochem Biophys Res Commun. 2020 Dec 17;533(4):867-871. (PMID: 33008593)
J Gen Virol. 2012 Apr;93(Pt 4):722-732. (PMID: 22238232)
Int J Cardiol. 2013 Mar 10;163(3):299-304. (PMID: 21724278)
Autophagy. 2015;11(2):271-84. (PMID: 25650776)
Immunology. 2006 Mar;117(3):301-9. (PMID: 16476049)
Am J Pathol. 2006 Dec;169(6):2085-93. (PMID: 17148671)
Oncotarget. 2016 Feb 23;7(8):9429-47. (PMID: 26882566)
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d. (PMID: 23824828)
Viral Immunol. 2014 Apr;27(3):88-95. (PMID: 24702483)
Cardiovasc Res. 2023 Jan 18;118(17):3331-3345. (PMID: 35426438)
N Engl J Med. 2009 Apr 9;360(15):1526-38. (PMID: 19357408)
Virol J. 2016 Oct 10;13(1):168. (PMID: 27724948)
J Immunol Res. 2018 May 7;2018:5301548. (PMID: 29854842)
Front Neurol. 2019 Aug 07;10:853. (PMID: 31447768)
FASEB J. 2018 Jun 4;:fj201701408R. (PMID: 29863913)
Virus Res. 2015 Oct 2;208:22-9. (PMID: 26052084)
Biochem Biophys Res Commun. 2007 Nov 23;363(3):495-9. (PMID: 17888876)
Virulence. 2018;9(1):1364-1376. (PMID: 30176160)
J Immunol. 2013 Jul 1;191(1):283-92. (PMID: 23733876)
Curr Med Chem. 2008;15(20):1976-80. (PMID: 18691053)
Int J Biol Macromol. 2019 Apr 1;126:179-186. (PMID: 30586589)
Int Immunol. 1999 May;11(5):777-86. (PMID: 10330283)
Mediators Inflamm. 2021 May 12;2021:5551578. (PMID: 34093086)
J Immunol. 2005 Jul 1;175(1):517-22. (PMID: 15972687)
Front Immunol. 2020 Oct 22;11:570681. (PMID: 33193350)
J Mol Cell Cardiol. 2012 Jul;53(1):6-14. (PMID: 22446162)
Virulence. 2021 Dec;12(1):360-376. (PMID: 33380272)
Infect Chemother. 2015 Mar;47(1):12-26. (PMID: 25844259)
Am J Physiol Lung Cell Mol Physiol. 2014 Jan;306(2):L183-95. (PMID: 24242010)
Trends Immunol. 2002 Jul;23(7):323-5. (PMID: 12103338)
Arthritis Rheumatol. 2015 May;67(8):2185-95. (PMID: 25891969)
J Neuroinflammation. 2012 Apr 05;9:64. (PMID: 22480370)
Curr Opin Rheumatol. 2012 Jul;24(4):401-7. (PMID: 22488075)
J Crohns Colitis. 2022 Nov 23;16(11):1751-1761. (PMID: 35833587)
Immunobiology. 2006;211(3):167-78. (PMID: 16530084)
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6360-5. (PMID: 11353871)
Cell. 1995 Jan 27;80(2):213-23. (PMID: 7834741)
Clin Infect Dis. 2007 May 15;44(10):e78-81. (PMID: 17443457)
J Immunol. 2006 Oct 1;177(7):4870-9. (PMID: 16982929)
Virus Res. 2016 Feb 2;213:314-321. (PMID: 26779987)
Nat Rev Cardiol. 2015 Nov;12(11):670-80. (PMID: 26194549)
PLoS Pathog. 2014 Oct 02;10(10):e1004422. (PMID: 25275585)
PLoS One. 2017 Mar 24;12(3):e0174019. (PMID: 28339476)
Cell Mol Immunol. 2019 Jun;16(6):568-579. (PMID: 29563614)
Circ Res. 2017 Sep 15;121(7):803-818. (PMID: 28912184)
Annu Rev Pathol. 2008;3:127-55. (PMID: 18039131)
Virus Res. 1985 Oct;3(3):263-70. (PMID: 3000101)
PLoS One. 2010 Oct 23;5(10):e15390. (PMID: 21060663)
J Leukoc Biol. 2015 Jul;98(1):33-48. (PMID: 25977287)
Rheumatology (Oxford). 2009 Jul;48(7):721-6. (PMID: 19429906)
Apoptosis. 2007 Mar;12(3):513-24. (PMID: 17195095)
J Immunol. 2010 Oct 1;185(7):4004-10. (PMID: 20802148)
Lancet. 2012 Feb 25;379(9817):738-47. (PMID: 22185868)
mBio. 2021 Mar 23;12(2):. (PMID: 33758083)
- Contributed Indexing:
Keywords: CD147; T cell activation; Th cell subsets; anti-inflammation; viral myocarditis
- Accession Number:
0 (AC-73)
0 (Cytokines)
- Publication Date:
Date Created: 20230527 Date Completed: 20230529 Latest Revision: 20230530
- Publication Date:
20240829
- Accession Number:
PMC10221111
- Accession Number:
10.3390/v15051137
- Accession Number:
37243223
No Comments.